Jl. Davideau et al., IN-SITU INVESTIGATION OF VITAMIN-D-RECEPTOR, ALKALINE-PHOSPHATASE, AND OSTEOCALCIN GENE-EXPRESSION IN OROFACIAL MINERALIZED TISSUES, Endocrinology, 137(8), 1996, pp. 3577-3585
The aim of this study was to investigate the expression pattern of 1,2
5-dihydroxyvitamin D-3 receptor (VDR) and vitamin D-responsive gene ex
pression during the steps of hard tissue formation in ore-facial devel
opment. In situ hybridization of VDR, alkaline phosphatase, and osteoc
alcin transcripts was performed in the mandibles of growing rats. Oste
oblasts were used as the internal positive control for in situ detecti
on of VDR messenger RNAs. Transcripts were present throughout the stag
es of differentiation and in differentiated osteoblasts and osteocytes
, and showed some anatomical specificities in their developmental expr
ession pattern. In dental tissues, VDR was strongly expressed in the i
nner dental epithelium at the beginning of the presecretion stage and,
after a transient decrease at the end of the presecretion stage, in s
ecretion stage ameloblasts. VDR was continuously expressed in epitheli
al supraameloblastic cells. During dentin formation, VDR was mainly pr
esent in subodontoblastic cells and was down-regulated during the term
inal differentiation of odontoblasts. In these cells, VDR expression a
ppeared to be induced by 1,25-dihydroxyvitamin D-3 injection. These da
ta confirm that VDR is expressed in cells directly involved in mineral
ized tissue formation: ameloblasts, odontoblasts, and osteoblasts. Fur
thermore, they extend the idea of vitamin D sensitivity to cells that
are not directly involved in this process: supraameloblastic, subodont
oblastic, and osteoprogenitor cells. The differential expression patte
rn of VDR in odontoblasts and osteoblasts together with the similarity
in the expression of potential vitamin D-responsive genes (osteocalci
n in odontoblasts and osteoblasts, and alkaline phosphatase in osteopr
ogenitor and subodontoblastic cells) suggest the existence of a tissue
specificity for the genomic action of 1,25-dihydroxyvitamin D-3, whic
h may involve cooperation with additional nuclear factors.